Your browser doesn't support javascript.
loading
Antibiotic allergy labels in immunocompromised populations.
Waldron, Jamie L; Trubiano, Jason A.
Afiliación
  • Waldron JL; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.
  • Trubiano JA; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.
Transpl Infect Dis ; 24(5): e13955, 2022 Oct.
Article en En | MEDLINE | ID: mdl-36254502
ABSTRACT
Antibiotic allergy labels (AALs) are commonly reported, with well-defined prevalence in the general population; several studies have now focused efforts on immunocompromised hosts. Understanding the prevalence of reported allergy labels and methods of antibiotic allergy evaluation and delabeling strategies has the potential to improve prescribing practices and clinical outcomes in this high-antibiotic use group. In this review, we will discuss the current literature on the prevalence, impact, and evaluations of AALs in immunocompromised hosts with a focus on beta-lactam (penicillin) allergy and sulfa-antibiotic (antimicrobial sulfurs) allergy labels.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Hipersensibilidad a las Drogas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Asunto principal: Hipersensibilidad a las Drogas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Australia